# MOv19-BBz CAR T Cells in FRa+ Cancers

> **NCT07116057** · PHASE1 · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 10 (estimated)

## Conditions studied

- Metastatic Non Small Cell Lung Cancer
- Recurrent Lung Non-Small Cell Carcinoma

## Interventions

- **BIOLOGICAL:** MOv19-BBz CAR T cells
- **DRUG:** Cyclophosphamide/Fludarabine
- **DEVICE:** FRa Expression Testing

## Key facts

- **NCT ID:** NCT07116057
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-07
- **Primary completion:** 2040-10
- **Final completion:** 2040-10
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116057, "MOv19-BBz CAR T Cells in FRa+ Cancers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07116057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*